People · Operator

Jeff B. Montie

Named in public records as an officer, director or promoter · active 2018–2018 · Other Health Care

1
Companies
1
Filings
$52.3M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NOWDiagnostics, Inc.Other Health CareSeries B$52.3M$420.4M2018
Operator network

Jeff B. Montie at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Clete Brewer · 8 companies · 1 sharedClete BrewerAlan Chang · 4 companies · 1 sharedAlan ChangKevin Clark · 4 companies · 1 sharedKevin ClarkJeremy Wilson · 3 companies · 1 sharedJeremy WilsonChuck Farkas · 2 companies · 1 sharedChuck FarkasDoug Degn · 2 companies · 1 sharedDoug DegnAnn Bordelon · 1 companies · 1 sharedAnn BordelonCharles B. Farkas · 1 companies · 1 sharedCharles B. FarkasDoug B. Degn · 1 companies · 1 sharedDoug B. DegnGerald Gallwas · 1 companies · 1 sharedGerald GallwasGerald Galwas · 1 companies · 1 sharedGerald GalwasJeff Montie · 1 companies · 1 sharedJeff MontieJerry Galwns · 1 companies · 1 sharedJerry GalwnsJohn B. Harley · 1 companies · 1 sharedJohn B. HarleyJohn Harley · 1 companies · 1 sharedJohn HarleyQinwei Shi · 1 companies · 1 sharedQinwei ShiNOWDiagnostics, Inc. · $52.3M raisedNOWDiagnostics, Inc.Jeff B. MontieJM
Jeff B. Montie Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Jeff B. Montie on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Clete Brewer18
Alan Chang14
Kevin Clark14
Jeremy Wilson13
Chuck Farkas12
Doug Degn12
Gerald Gallwas11
Charles B. Farkas11
John B. Harley11
Qinwei Shi11
Doug B. Degn11
John Harley11
Jerry Galwns11
Gerald Galwas11
Jeff Montie11
Ann Bordelon11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.